香港股市今日交易中，荣昌生物（09995.HK）股价出现大幅下跌，盘中跌幅一度达到5.07%，引发市场关注。
据港交所最新披露信息显示，7月8日，荣昌生物大股东将价值4.76亿港元的股票从沪港通转入香港上海汇丰银行，占公司总股本的3.54%。这一大额转仓操作可能引发了市场对潜在抛售压力的担忧，成为今日股价下跌的主要原因之一。
此外，荣昌生物近期的业务动态也可能对股价产生影响。公司此前宣布，其抗体偶联药物维迪西妥单抗的一项新适应症上市许可申请已获国家药监局受理。同时，公司于6月26日对外公布，将向Vor Bio授予泰它西普大中华区外独家开发权，交易总价值1.25亿美元。这些消息对公司股价的影响仍有待市场进一步消化。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.